Published in Arch Dermatol on August 01, 1969
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25
The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J (2015) 1.06
IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge. Arch Dermatol Res (1985) 0.97
Treatment of dermatitis herpetiformis with corticosteroids and a gluten-free diet: a study of jejunal morphology and function. Gut (1973) 0.94
Intestinal malabsorption and the skin. Gut (1971) 0.90
Failure to detect specific gluten antigens associated with the immune aggregates in the skin in dermatitis herpetiformis. Arch Dermatol Res (1977) 0.90
Gluten challenge in children with dermatitis herpetiformis: a clinical, morphological and immunohistological study. Gut (1986) 0.89
The gut and the skin. Postgrad Med J (1970) 0.83
Response of the skin in dermatitis herpetiformis to a gluten free diet, with reference to jejunal morphology. Gut (1978) 0.79
Dermatitis herpetiformis and gluten-free diet. Br Med J (1970) 0.79
Dermatitis herpetiformis: a comparative assessment of skin and bowel abnormality. J Clin Pathol (1977) 0.75
The gut and dermatitis herpetiformis. Br Med J (1971) 0.75
Excitatory and inhibitory interactions in localized populations of model neurons. Biophys J (1972) 8.60
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
A mathematical theory of the functional dynamics of cortical and thalamic nervous tissue. Kybernetik (1973) 4.68
Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther (2012) 3.16
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol (1984) 2.93
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol (1984) 2.54
The ultrastructure of the gall-bladder epithelium of the dog. J Anat (1962) 2.48
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
A mathematical theory of visual hallucination patterns. Biol Cybern (1979) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Geometric visual hallucinations, Euclidean symmetry and the functional architecture of striate cortex. Philos Trans R Soc Lond B Biol Sci (2001) 2.16
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today (1995) 2.09
Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med (1997) 1.98
Effect of light on the Lactobacillus casei icrobiological assay. J Clin Pathol (1968) 1.95
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Clearance of psoriasis with low dose cyclosporin. Br Med J (Clin Res Ed) (1986) 1.75
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
Dermatitis herpetiformis: an evaluation of diagnostic criteria. Br J Dermatol (1974) 1.66
Resonance effect for neural spike time reliability. J Neurophysiol (1998) 1.62
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol (2009) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol (1992) 1.57
Binding of wheat gliadin in vitro to reticulum in normal and dermatitis herpetiformis skin. J Invest Dermatol (1981) 1.57
Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol (1982) 1.56
Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol (2003) 1.56
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br J Dermatol (1987) 1.53
The cytology of repair in experimental perforations of the tympanic membrane. Br J Surg (1966) 1.52
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed) (1983) 1.45
Use of cyclosporin in psoriasis. Lancet (1990) 1.43
Long-term cyclosporin for psoriasis. Br J Dermatol (1989) 1.42
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
What matters in neuronal locking? Neural Comput (1996) 1.41
Medical anatomists--a dying race. Ann R Coll Surg Engl (1979) 1.39
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Cyclosporin toxicity. Lancet (1990) 1.38
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Anti-gliadin antibodies and small intestinal mucosal damage in dermatitis herpetiformis. Br J Dermatol (1981) 1.35
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Rubella, 1962. Br Med J (1962) 1.33
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Immunoglobulins in the skin in dermatitis herpetiformis and their relevance in diagnosis. Br J Dermatol (1975) 1.32
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29